Bumrungrad Hospital Public : Notification on acquisition of shares of a company in Swiss Confederation

Ref: SET 60/06

24 January 2017

Subject: Notification on acquisition of shares of a company in Swiss Confederation To: Directors and Manager

The Stock Exchange of Thailand

Whereas the Investment Committee Meeting No. 2/2016, held on 28 July 2016, has resolved to approve the Company's investment in Switzerland. Bumrungrad Hospital Public Company Limited (the "Company") would like to inform you that Life and Longevity Limited, a wholly owned subsidiary of the Company, registered in Hong Kong Special Administrative Regions of the People's Republic of China, has now completed the acquisition of shares of a company in Swiss Confederation. The details are as follows:

1. Date registered

   20 January 2017

2. Name of subsidiary

   Inovital International AG

3. Registered country Swiss Confederation

4. Type of business

   Manufacture and sale of vitamin supplement products and after sales services

5. Registered capital

   CHF 100,000 (one hundred thousand)

6. Shareholding structure

   Life and Longevity Limited holds 49% of the total shares, Inovex Holding AG holds 51% of the total shares

7. Source of funds

From the working capital of Life and Longevity Limited

The value of the acquisition of an associated company mentioned above is CHF 49,000 equals to Baht 1,747,369.40 or 0.013 per cent of the net tangible assets value in the immediate preceding six months and as such the acquisition is not classified as a connected transaction nor a transaction with the size of acquisition and disposal of assets subject to compliance with rules and regulations under the Notification of the Capital Market Supervisory Commission No. Tor Chor 20/2551 Re: Rules on Entering into Material Transactions Deemed as Acquisition or Disposal of Assets and the Notification of the Stock Exchange of Thailand (SET) Re: Disclosure of Information Concerning the Acquisition and Disposition of Assets of Listed Companies, B.E. 2547.

Please be informed accordingly.

Yours Faithfully,

(Dr. Chanvit Tanphiphat, MD) Vice Chairman